Cedars-Sinai Medical Center, Los Angeles, CA (J.K., M.L.L., S.C., D.D., D.S.B., P.J.S.).
BHF Centre for Cardiovascular Science, Clinical Research Imaging Centre, Edinburgh Heart Centre, University of Edinburgh, United Kingdom (J.K., P.D.A., M.K.D., A.J.M., M.A.J., M.R.D., D.E.N.).
Circ Cardiovasc Imaging. 2018 Dec;11(12):e008325. doi: 10.1161/CIRCIMAGING.118.008325.
We assessed the feasibility of utilizing previously acquired computed tomography angiography (CTA) with subsequent positron-emission tomography (PET)-only scan for the quantitative evaluation of F-NaF PET coronary uptake.
Forty-five patients (age 67.1±6.9 years; 76% males) underwent CTA (CTA1) and combined F-NaF PET/CTA (CTA2) imaging within 14 [10, 21] days. We fused CTA1 from visit 1 with F-NaF PET (PET) from visit 2 and compared visual pattern of activity, maximal standard uptake (SUVmax) values, and target to background ratio (TBR) measurements on (PET/CTA1) fused versus hybrid (PET/CTA2). On PET/CTA2, 226 coronary plaques were identified. Fifty-eight coronary segments from 28 (62%) patients had high F-NaF uptake (TBR >1.25), whereas 168 segments had lesions with F-NaF TBR ≤1.25. Uptake in all lesions was categorized identically on coregistered PET/CTA1. There was no significant difference in F-NaF uptake values between PET/CTA1 and PET/CTA2 (SUVmax, 1.16±0.40 versus 1.15±0.39; P=0.53; TBR, 1.10±0.45 versus 1.09±0.46; P=0.55). The intraclass correlation coefficient for SUVmax and TBR was 0.987 (95% CI, 0.983-0.991) and 0.986 (95% CI, 0.981-0.992). There was no fixed or proportional bias between PET/CTA1 and PET/CTA2 for SUVmax and TBR. Cardiac motion correction of PET scans improved reproducibility with tighter 95% limits of agreement (±0.14 for SUVmax and ±0.15 for TBR versus ±0.20 and ±0.20 on diastolic imaging; P<0.001).
Coronary CTA/PET protocol with CTA first followed by PET-only allows for reliable and reproducible quantification of F-NaF coronary uptake. This approach may facilitate selection of high-risk patients for PET-only imaging based on results from prior CTA, providing a practical workflow for clinical application.
我们评估了利用先前获得的计算机断层血管造影术(CTA)并随后进行正电子发射断层扫描(PET)仅扫描来对 F-NaF PET 冠状动脉摄取进行定量评估的可行性。
45 名患者(年龄 67.1±6.9 岁;76%为男性)在 14[10,21]天内接受了 CTA(CTA1)和 F-NaF PET/CTA(CTA2)联合成像。我们将第 1 次就诊的 CTA1 与第 2 次就诊的 F-NaF PET 融合,并比较了活动的视觉模式、最大标准摄取(SUVmax)值以及融合(PET/CTA1)与混合(PET/CTA2)上的靶与背景比(TBR)测量值。在 PET/CTA2 上,共确定了 226 个冠状动脉斑块。28 名(62%)患者中有 58 个冠状动脉节段有高 F-NaF 摄取(TBR>1.25),而 168 个节段有 F-NaF TBR≤1.25 的病变。所有病变的摄取在核配的 PET/CTA1 上均分类相同。PET/CTA1 与 PET/CTA2 之间的 F-NaF 摄取值无显著差异(SUVmax,1.16±0.40 与 1.15±0.39;P=0.53;TBR,1.10±0.45 与 1.09±0.46;P=0.55)。SUVmax 和 TBR 的组内相关系数为 0.987(95%CI,0.983-0.991)和 0.986(95%CI,0.981-0.992)。SUVmax 和 TBR 之间无固定或比例偏差。PET 扫描的心脏运动校正提高了可重复性,使 95%一致性界限更紧(±0.14 用于 SUVmax 和 ±0.15 用于 TBR,与舒张成像时的 ±0.20 和 ±0.20 相比;P<0.001)。
首先进行 CTA 然后仅进行 PET 的冠状动脉 CTA/PET 方案可实现 F-NaF 冠状动脉摄取的可靠和可重复定量。这种方法可以根据先前 CTA 的结果为仅进行 PET 成像的高危患者提供选择,为临床应用提供实用的工作流程。